AstralBio is a biotechnology company that offers medicines to treat cardiometabolic and immune-mediated diseases.
AstralBio has raised $957K in total funding. The most recent round was Seed. The last funding was announced in December 2024.
AstralBio is headquartered in Boston, United States.
AstralBio is a biotechnology company that offers medicines to treat cardiometabolic and immune-mediated diseases.
AstralBio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"AstralBio — Funding & Investors." VCBacked, December 19, 2024, https://www.vcbacked.co/company/astralbio. Accessed July 19, 2026.
VCBacked. (2024). AstralBio — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/astralbio
{{cite web |title=AstralBio — Funding & Investors |url=https://www.vcbacked.co/company/astralbio |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated